Clinical trials show progress in migraine frequency, skin cancer prevention

-
1:44
’When it’s empty, it’s not living its full potential’:...
-
2:14
Temps and humidity increase to start the new work week but rain...
-
3:35
Hartland Kids Day 2025 -- here’s what to expect
-
2:35
Popular Milwaukee rapper and promoter 1 of 2 killed in Water...
-
1:14
Milwaukee native Mitch Voit gets MLB draft day call
-
1:32
Nashotah Park
-
4:13
Safari Lake Geneva brings family fun and a chance to meet over...
-
3:36
A historic Milwaukee cemetery has its own honey, and millions...
-
3:38
Owners of Little Read Book in Wauwatosa celebrate 40 years of...
-
4:59
Group of Nicolet High School seniors achieve national recognition...
-
2:17
Smoky Sunday then a mild Monday, rain holds off for a while
-
0:33
Skate Milwaukee provides competition experience⛸️
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.